Search results for 2)

Anti-JIP-2/IB-2 Antibody (N135/13), AntibodySystem, RHG50601

Anti-JIP-2/IB-2 Antibody (N135/23), AntibodySystem, RHG50602

Anti-JIP-2/IB-2 Antibody (N135/37), AntibodySystem, RHG50603

SARS-CoV-2 RBD (KP.2) ELISA Kit, ProteoGenix, KPTX424

Description of SARS-CoV-2 RBD (KP.2) ELISA Kit Introduction to SARS-CoV-2 RBD (KP.2) ELISA Kit The SARS-CoV-2 RBD (KP.2) ELISA Kit is a highly sensitive and specific diagnostic tool used for the detection of antibodies against the receptor binding domain (RBD) of the SARS-CoV-2 virus. This kit is designed for use in research settings and has the potential to be used as a therapeutic target for the development of treatments for COVID-19. Structure of SARS-CoV-2 RBD (KP.2) ELISA Kit The SARS-CoV-2 RBD (KP.2) ELISA Kit is composed of several components including microtiter plates, enzyme-linked immunosorbent assay (ELISA) reagents, and positive and negative controls. The microtiter plates are coated with highly purified recombinant RBD protein, which is specific to SARS-CoV-2. The ELISA reagents consist of enzyme-conjugated antibodies that are specific to human IgG, IgM, and IgA antibodies. These antibodies will bind to any SARS-CoV-2 RBD antibodies present in the sample. The positive and negative controls are used to ensure the accuracy and reliability of the test results. Activity of SARS-CoV-2 RBD (KP.2) ELISA Kit The SARS-CoV-2 RBD (KP.2) ELISA Kit works by detecting the presence of antibodies against the RBD of the SARS-CoV-2 virus in a patient’s blood sample. The RBD is a key component of the virus that is responsible for binding to the ACE2 receptor on human cells, allowing the virus to enter and infect the cells. When a person is infected with SARS-CoV-2, their immune system produces antibodies against the RBD as a response to the virus. These antibodies can be detected in the blood, indicating a past or current infection with the virus. The ELISA procedure involves adding the patient’s blood sample to the microtiter plate, which is coated with the RBD protein. If the patient has been exposed to the virus, their blood will contain antibodies that will bind to the RBD protein on the plate. The ELISA reagents are then added, which will bind to the antibodies present in the sample. A color change is then observed, indicating a positive result. The intensity of the color change is directly proportional to the amount of antibodies present in the sample, allowing for quantitative measurement of antibody levels. Application of SARS-CoV-2 RBD (KP.2) ELISA Kit The SARS-CoV-2 RBD (KP.2) ELISA Kit has multiple applications, including research use and potential therapeutic targeting. In research settings, this kit can be used to study the immune response to SARS-CoV-2 and track the spread of the virus. It can also be used to evaluate the effectiveness of vaccines and potential treatments for COVID-19. Furthermore, the RBD protein has been identified as a potential therapeutic target for the development of treatments for COVID-19. By targeting the RBD, it may be possible to prevent the virus from binding to human cells and causing infection. The SARS-CoV-2 RBD (KP.2) ELISA Kit can play a crucial role in identifying and selecting potential therapeutic compounds that block the interaction between the RBD and the ACE2 receptor. Conclusion The SARS-CoV-2 RBD (KP.2) ELISA Kit is a valuable diagnostic tool for the detection of antibodies against the RBD of the SARS-CoV-2 virus. Its high sensitivity and specificity make it a reliable choice for research use and potential therapeutic targeting. With the ongoing COVID-19 pandemic, this kit can aid in understanding the immune response to the virus and contribute to the development of effective treatments.

Mitotic Arrest Deficient 2 Like 2 (MAD2L2) Antibody, Abbexa, abx135805

MAD2L2 Antibody is a Rabbit Polyclonal against MAD2L2.

Melanocortin 2 Receptor Accessory Protein 2 (MRAP2) Antibody, Abbexa, abx318650

MRAP2 Antibody is a Rabbit Polyclonal against MRAP2.

PE Anti-Dynamin 2 antibody [EPR9053(2)(ABC)], Abcam, AB318383

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies . How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone.

AP-2 Complex Subunit Alpha 2 (AP2A2) Antibody, Abbexa, abx230461

AP2A2 Antibody is a Rabbit Polyclonal against AP2A2.

CMRF35-Like Molecule 2 / IREM-2 (CD300E) Antibody, Abbexa, abx030830

CD300E probably acts as an activating receptor.

Anti-Glutathione Peroxidase 2/GPX2 antibody [EPR8175(2)], Abcam, AB140130

Species reactivity Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species. Please contact us for more information. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .